论文部分内容阅读
选取我院2013年8月~2015年10月收治的182例反流性食管炎患者,按照患者住院的先后顺序,分成观察组和对照组,各91例。观察组通过泮托拉唑联合铝碳酸镁治疗,对照组通过单纯泮托拉唑治疗,对比两组临床效果。结果观察组的治疗总有效率96.70%,明显高于对照组的治疗总有效率84.62%,差异具有统计学意义,P<0.05。结论反流性食管炎经泮托拉唑、铝碳酸镁联合治疗,临床疗效确切,且治疗安全性较高,值得临床深入推广。
A total of 182 reflux esophagitis patients admitted from August 2013 to October 2015 in our hospital were divided into observation group and control group according to the order of patients’ hospitalization, each of 91 patients. The observation group was treated with pantoprazole and aluminum magnesium carbonate, while the control group was treated with pantoprazole alone. The clinical effects were compared between the two groups. Results The total effective rate of observation group was 96.70%, significantly higher than the control group, the total effective rate was 84.62%, the difference was statistically significant, P <0.05. Conclusion Reflux esophagitis by pantoprazole, aluminum magnesium carbonate combination therapy, clinical curative effect is exact, and the treatment of safety is high, it is worth clinical in-depth promotion.